Comparative Incidence of Urinary Tract Infections in Diabetic Women Treated with Dapagliflozin Versus Empagliflozin: A Double-Blind Randomized Clinical Trial.

Kazem-Nadi S, Keshtkari S, Labbani-Motlagh Z, Mousavi V

Open source

DOI
10.5812/ijem-168824
Published
2026 Oct 31
Container
International journal of endocrinology and metabolism
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5812/ijem-168824,
  title = {Comparative Incidence of Urinary Tract Infections in Diabetic Women Treated with Dapagliflozin Versus Empagliflozin: A Double-Blind Randomized Clinical Trial.},
  author = {Kazem-Nadi S and Keshtkari S and Labbani-Motlagh Z and Mousavi V},
  year = {2026},
  journal = {International journal of endocrinology and metabolism},
  doi = {10.5812/ijem-168824},
  url = {https://doi.org/10.5812/ijem-168824}
}

RIS

TY  - JOUR
TI  - Comparative Incidence of Urinary Tract Infections in Diabetic Women Treated with Dapagliflozin Versus Empagliflozin: A Double-Blind Randomized Clinical Trial.
AU  - Kazem-Nadi S
AU  - Keshtkari S
AU  - Labbani-Motlagh Z
AU  - Mousavi V
PY  - 2026
JO  - International journal of endocrinology and metabolism
DO  - 10.5812/ijem-168824
UR  - https://doi.org/10.5812/ijem-168824
ER  - 

APA

S, K., S, K., Z, L., & V, M. (2026). Comparative Incidence of Urinary Tract Infections in Diabetic Women Treated with Dapagliflozin Versus Empagliflozin: A Double-Blind Randomized Clinical Trial.. International journal of endocrinology and metabolism. https://doi.org/10.5812/ijem-168824

Source records